HealthEquity (NASDAQ:HQY) Given “Outperform” Rating at Barrington Research

Barrington Research restated their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a research report report published on Friday, Benzinga reports. They currently have a $100.00 price target on the stock.

Several other equities analysts have also commented on the company. Royal Bank of Canada upped their target price on HealthEquity from $90.00 to $92.00 and gave the company an outperform rating in a research note on Wednesday. Bank of America upped their target price on HealthEquity from $93.00 to $97.00 and gave the stock a buy rating in a research report on Wednesday. BTIG Research increased their price target on HealthEquity from $100.00 to $110.00 and gave the company a buy rating in a report on Wednesday. Barclays increased their price target on HealthEquity from $84.00 to $104.00 and gave the company an overweight rating in a report on Friday, February 23rd. Finally, Wells Fargo & Company increased their target price on HealthEquity from $89.00 to $93.00 and gave the stock an overweight rating in a report on Wednesday, December 6th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, HealthEquity has an average rating of Moderate Buy and a consensus target price of $92.55.

HealthEquity Stock Performance

NASDAQ HQY opened at $79.63 on Friday. The stock has a market cap of $6.83 billion, a price-to-earnings ratio of 124.42, a price-to-earnings-growth ratio of 1.27 and a beta of 0.53. The business has a fifty day moving average of $79.35 and a 200-day moving average of $73.00. HealthEquity has a fifty-two week low of $48.86 and a fifty-two week high of $84.49. The company has a quick ratio of 4.93, a current ratio of 4.76 and a debt-to-equity ratio of 0.43.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 2,586 shares of HealthEquity stock in a transaction on Monday, January 8th. The stock was sold at an average price of $70.00, for a total transaction of $181,020.00. Following the sale, the executive vice president now owns 52,495 shares of the company’s stock, valued at approximately $3,674,650. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 7,643 shares of company stock valued at $592,205 in the last quarter. Corporate insiders own 2.70% of the company’s stock.

Institutional Trading of HealthEquity

A number of hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. grew its holdings in shares of HealthEquity by 0.6% in the 2nd quarter. BlackRock Inc. now owns 10,346,280 shares of the company’s stock worth $653,264,000 after acquiring an additional 58,684 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of HealthEquity by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 8,619,499 shares of the company’s stock valued at $571,473,000 after buying an additional 104,084 shares in the last quarter. Wasatch Advisors Inc. boosted its position in HealthEquity by 3.3% during the first quarter. Wasatch Advisors Inc. now owns 7,638,935 shares of the company’s stock valued at $515,170,000 after purchasing an additional 244,868 shares during the last quarter. FMR LLC boosted its position in HealthEquity by 19.1% during the third quarter. FMR LLC now owns 5,648,992 shares of the company’s stock valued at $412,659,000 after purchasing an additional 907,743 shares during the last quarter. Finally, State Street Corp boosted its position in HealthEquity by 2.4% during the second quarter. State Street Corp now owns 2,816,282 shares of the company’s stock valued at $177,820,000 after purchasing an additional 65,809 shares during the last quarter. Institutional investors own 98.46% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.